首页> 美国卫生研究院文献>The Journal of Pharmacology and Experimental Therapeutics >Activation of Adenosine1 Receptors Induces Antidepressant-Like Anti-Impulsive Effects on Differential Reinforcement of Low-Rate 72-s Behavior in Rats
【2h】

Activation of Adenosine1 Receptors Induces Antidepressant-Like Anti-Impulsive Effects on Differential Reinforcement of Low-Rate 72-s Behavior in Rats

机译:腺苷1受体的激活诱导大鼠低速72-s行为差异增强的抗抑郁样抗冲动作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stress and psychiatric illness have been associated with a dysregulation of glutamatergic neurotransmission. Recently, positive allosteric modulators (PAMs) of the metabotropic glutamate 2 (mGlu2) receptor have been found to exert antidepressant-like activity in rats performing under a differential reinforcement of low rate (DRL) 72-s schedule. An autoreceptor role at glutamatergic synapses is the most salient physiological role played by the mGlu2 receptor. Adenosine A1 receptors play a heteroreceptor role at many of the same forebrain synapses where mGlu2 autoreceptors are found. Agonists and/or PAMs of mGlu2 receptors act similarly to adenosine A1 receptor agonists with respect to a wide range of electrophysiological, biochemical, and behavioral responses mediated by limbic circuitry thought to play a role in the pathophysiology of neuropsychiatric disease and to mediate therapeutic drug effects. Therefore, the role of adenosine A1 receptor activation on rat DRL 72-s behavior was explored to provide preclinical evidence consistent or inconsistent with potential antidepressant effects. The adenosine A1 receptor agonist N6-cyclohexyladenosine (CHA) increased the reinforcement rate, decreased the response rate, and induced a rightward shift in inter-response time distributions in a dose-dependent fashion similar to most known antidepressant drugs. The adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) blocked these antidepressant-like effects. These novel observations with CHA and DPCPX suggest that activation of adenosine A1 receptors could contribute to antidepressant effects, in addition to previous preclinical reports of anxiolytic and antipsychotic effects. By implication, targeting a dysregulated glutamatergic system may be an important principle in discovering novel antidepressant agents that may also possess anti-impulsive activity.
机译:压力和精神疾病与谷氨酸能神经传递失调有关。最近,已发现代谢型谷氨酸2(mGlu2)受体的正变构调节剂(PAMs)在低速(DRL)72-s时间表的增强作用下的大鼠中发挥抗抑郁样活性。谷氨酸能突触的自体受体作用是mGlu2受体发挥的最显着的生理作用。腺苷A1受体在发现mGlu2自身受体的许多相同的前脑突触中发挥异源受体的作用。关于mGlu2受体的激动剂和/或PAM与腺苷A1受体激动剂的作用相似,涉及范围广泛的电生理,生化和行为反应,这些反应由边缘电路介导,被认为在神经精神疾病的病理生理中起作用并介导治疗性药物作用。因此,探讨了腺苷A1受体激活对大鼠DRL 72-s行为的作用,以提供与潜在抗抑郁作用一致或不一致的临床前证据。腺苷A1受体激动剂N 6 -环己基腺苷(CHA)以类似于大多数药物的剂量依赖性方式提高补强率,降低应答率,并引起应答间时间分布的右移。抗抑郁药。腺苷A1受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)阻止了这些抗抑郁药样作用。这些关于CHA和DPCPX的新颖观察表明,除了以前的抗焦虑和抗精神病作用的临床前报道外,腺苷A1受体的激活还可能有助于抗抑郁作用。通过暗示,靶向失调的谷氨酸能系统可能是发现还具有抗冲动活性的新型抗抑郁药的重要原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号